Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Innogenetics Acquires PCR License

By Labmedica staff writers
Posted on 07 Nov 2005
An agreement has been announced whereby Roche Diagnostics (Basel, Switzerland) has granted a full, worldwide license for the use of its patented polymerase chain reaction (PCR) technology to Innogentics GmbH (Ghent, Belgium) in the development and commercialization of Innogenetics' molecular diagnostic products.

Under the terms of the agreement, Innogenetics will pay Roche up to U.S.$27.5 million over a four-year period, plus royalties. More...
This broad license will replace the current product-specific licensing agreement, thereby enabling Innogenetics to offer its customers the complete set of PCR reagents and processes to perform PCR-based nucleic acid amplification so they will not have to obtain a separate license from Roche for this purpose. The deal will also allow Innogenetics to fully integrate PCR technology in its next-generation diagnostic platform as well as its complete range of molecular diagnostic tests, thereby ensuring the best test performance.

"We are extremely pleased to have concluded this milestone agreement with Roche Diagnostics,” observed Frank Morich, CEO of Innogenetics. "The availability of PCR for all of our current and future nucleic-acid-based tests will allow us to capitalize on the full potential of our new technology platform, offer our customers the broadest and most up-to-date options for diagnostic testing, and provide Innogenetics with the strategic freedom to further diversify its product offerings and increase diagnostic sales.”





Related Links:
Roche Diagnostics
Innogenetics

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.